Unraveling the link between leptin, ghrelin and different types of colitis

por Tiaka, Elisavet K., Manolakis, Anastassios C., Kapsoritakis, Andreas N., Potamianos, Spyros P.
Publicado 2011

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome

por Manolakis, Anastassios C, Kapsoritakis, Andreas N, Georgoulias, Panagiotis, Tzavara, Chara, Valotassiou, Varvara, Kapsoritaki, Anastasia, Potamianos, Spyros P
Publicado 2010

α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease

por Manolakis, Anastassios C, Christodoulidis, Gregory, Kapsoritakis, Andreas N, Georgoulias, Panagiotis, Tiaka, Elisavet K, Oikonomou, Kostas, Valotassiou, Varvara J, Potamianos, Spyros P
Publicado 2017

Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease

por Kapsoritakis, Andreas N, Kapsoritaki, Anastasia I, Davidi, Ioanna P, Lotis, Vasilios D, Manolakis, Anastasios C, Mylonis, Petros I, Theodoridou, Aikaterini T, Germenis, Anastasios E, Potamianos, Spyros P
Publicado 2008

Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model

por Kamposioras, Konstantinos, Tsimplouli, Chrysiida, Verbeke, Caroline, Anthoney, Alan, Daoukopoulou, Argyro, Papandreou, Christos N., Sakellaridis, Nikolaos, Vassilopoulos, George, Potamianos, Spyros P., Liakouli, Vasiliki, Migneco, Gemma, Galdo, Francesco Del, Dimas, Konstantinos
Publicado 2018